Defence Therapeutics Inc.
DTC
Classement en actions
#29464
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Prix de l'action
$0.25964327
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$19.68M
Changement (1 jour)
0.00%
Changement (1 an)
-55.64%
Pays
CA
Échange Defence Therapeutics Inc. (DTC)
Catégorie
Healthcare
Historique du prix de l'action pour Defence Therapeutics Inc. (DTC)
Prix de clôture le plus élevé : $0.27 le 2026-10-01
Prix de clôture le plus bas : $2.50 le 2021-05-01
Prix de clôture le plus bas : $2.50 le 2021-05-01
Historique du prix de l'action de Defence Therapeutics Inc. de 2021 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
